^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Soft Tissue Sarcoma |
| Regimen: | AD (dacarbazine + pegylated liposomal doxorubicin) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/28/2021
Excerpt:
Soft Tissue Sarcoma: Other Recommended Regimens...AD (doxorubicin, dacarbazine)
